Treace Medical Concepts Inc (TMCI)
Treace Medical Concepts, Inc. is a healthcare equipment and supplies company focused on medical technology for bunion and related foot deformity correction. The company develops, manufactures, and markets a portfolio of surgical systems and instruments in the United States. Its offerings include the Lapiplasty System, which is designed to correct bunion deformity in three dimensions and stabilize the first TMT joint, along with minimally invasive solutions such as Nanoplasty 3D and Percuplasty. Treace also provides products for other foot and midfoot conditions, including the Adductoplasty System, SpeedMTP, SpeedPlate implant platforms, and SpeedAkin. In addition, the company sells patient-specific planning and instrumentation tools, release and contouring instruments, and biologics and wedges used in surgical procedures. Treace Medical Concepts was founded in 2013 and is headquartered in Ponte Vedra, Florida.
Jump directly to the stock analysis sections supported by the latest available data.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Analyst Target Rating | Overall Financial Health | Dividend Yield | Next Earnings Date | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
NASDAQ-TMCI
|
$5.95
|
29.6% Upside
|
Undervalued
|
$5.50
|
19.8% Upside
|
Undervalued
|
Fair
|
0.0%
|
November 10, 2026
|
4.3x
|
1.4x
|
298.5 M
|
318.8 M
|
19.7%
|
73.6%
|
-0.1
|
42.1%
|
